Prodrug Design Targeting Intestinal PepT1 for Improved Oral Absorption: Design and Performance

Author(s): Youxi Zhang, Jin Sun, Yongbing Sun, Yongjun Wang, Zhonggui He

Journal Name: Current Drug Metabolism

Volume 14 , Issue 6 , 2013

Become EABM
Become Reviewer
Call for Editor


Oligopeptide transporter 1 (PepT1) plays an essential role in the oral absorption of di-and tripeptides from the digestion of ingested protein. PepT1 has become a striking prodrug-designing target recently, since some poorly absorbed drugs can be modified as peptidomimetic prodrugs targeting intestinal PepT1 to improve membrane permeability, and eventually oral absorption of the parent drug. However, little and no comprehensive attempts have been made to especially focus on the recent developments of prodrugs targeting intestinal PepT1. This article summarized biology, transport mechanism, structure-transport requirements for PepT1 and significant advances on the PepT1-targeted prodrugs within the two decades. The article also aimed to highlight some inspirations and knowledge on the multifunctional PepT1-targeted design, which are necessary for obtaining optimal prodrug candidates. That is the requirements of multifunctional rational PepT1 prodrugs include enough binding affinity for PepT1, controlled or targeted release of parent drug, escapement from P-gp mediated efflux and enhanced chemical/metabolic stability. Several types of peptidomimetic prodrugs reported recently were discussed in detail in this review.

Keywords: Oligopeptide transporter 1, oral absorption, prodrugs, substrates structure specificity.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Page: [675 - 687]
Pages: 13
DOI: 10.2174/1389200211314060004
Price: $65

Article Metrics

PDF: 79